SCHEMBL16424925

SCHEMBL16424925

CC1CCCC(=O)N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8283271 0.86 — —
Hydrochloric Acid SCHEMBL2520252 0.84 — —
SCHEMBL1303658 0.74 — —
SCHEMBL20200115 0.74 — —
Hydrochloric Acid SCHEMBL17187738 0.73 BRD4 (0.39) —
SCHEMBL20391285 0.73 — —
SCHEMBL10880843 0.73 — —
SCHEMBL16424982 0.73 — —
SCHEMBL13338064 0.72 BRD4 (0.31) —
SCHEMBL10865219 0.71 AKR1C3 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015010626-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF AGIOS PHARMACEUTICALS, INC. (US) 2015-01-29 — — WO disclosed
WO-2015010297-A1 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2015-01-29 — — WO disclosed
Send feedback